FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 11:31:14 2024-05-31 am EDT | ||
| 4.76 EUR | +5.78% |
|
| Current month | -8.81% | ||
| 1 month | -8.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 4.76 | +5.78% |
| 24-05-30 | 4.5 | -4.26% |
| 24-05-29 | 4.7 | -1.05% |
| 24-05-28 | 4.75 | +3.49% |
| 24-05-27 | 4.59 | +0.88% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 11:31 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12L4 |
| ISIN | DE000SV12L48 |
| Date issued | 2023-03-15 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.05 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.81 € |
|---|---|
| Lowest since issue | 3.67 € |
| Spread | 0.02 € |
| Spread % | 0.42% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Certificates
- Certificat
